X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://ec.europa.eu/digital-single-market/en/news/eu-and-south-korean-research-organisations-sign-agreement-work-together-development-covid-19
https://www.reuters.com/article/us-health-coronavirus-italy-drug/italy-okays-trial-of-osteoporosis-drug-to-treat-covid-19-idUSKBN27C136
https://www.pharmaceutical-technology.com/news/italy-osteoporosis-drug-covid/
https://www.pharmaceutical-technology.com/news/italy-osteoporosis-drug-covid/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211324
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2020-1582176609.pdf
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
http://www.pharmatimes.com/news/nice_backs_use_of_drugs_for_breast_cancer_prevention_1189858
https://www.pharma-excipients.ch/2017/01/20/formulation-and-evaluation-of-raloxifene-hydrochloride-tablets-with-improved-dissolution-profile/
http://www.pharmatimes.com/news/nice_backs_anastrozole_for_breast_cancer_prevention_1179364
http://www.business-standard.com/article/companies/dr-reddy-s-launches-osteoporosis-drug-in-us-market-116111100827_1.html
https://www.pharmacompass.com/pdf/news/scigens-generics-raloxifene-hydrochloride-approved-in-us-1477133262.pdf
http://www.thetimes.co.uk/article/carcinogen-ban-will-cost-jobs-eli-lilly-warns-sswgnvlvl
https://www.pharmacompass.com/pdf/news/amneals-generic-raloxifene-hcl-approved-in-us-for-osteoporosis-in-postmenopausal-women-1460462242.pdf
https://www.pharmacompass.com/pdf/news/glenmark-pharms-generic-raloxifene-hydrochloride-approved-in-us-to-treat-osteoporosis-in-postmenopausal-women-1459160237.pdf
http://www.fiercepharma.com/story/riding-q4-diabetes-growth-lilly-aims-even-more-jardiance/2016-01-28
http://www.fiercepharma.com/story/lilly-falls-short-analyst-forecasts-2016-guidance-weaker-end/2016-01-05
http://www.business-standard.com/article/opinion/compass-aurobindos-strong-run-to-continue-115112301023_1.html
http://www.fiercepharma.com/story/eli-lilly-can-thank-novartis-and-low-expectations-its-q1-earnings-beat/2015-04-23
http://www.pmlive.com/pharma_news/german_court_overturns_patent_on_lilly_blockbuster_alimta_672825
http://www.fool.com/investing/general/2015/04/05/10-largest-companies-by-market-cap-in-pharmaceutic.aspx
http://www.fiercepharma.com/story/lilly-execs-take-3m-hit-2014-bonuses-pay-freeze-thaws-2015/2015-03-30
http://www.fiercepharma.com/story/german-court-deals-another-eu-patent-blow-lillys-blockbuster-alimta/2015-03-06
http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking
http://www.pmlive.com/pharma_news/lilly_eyes_pivotal_trials_for_pain_drug_tanezumab_in_2015_642401
http://www.fiercepharma.com/story/lillys-sales-and-earnings-continue-their-free-fall-ceo-lechleiter-sees-good/2015-01-30
http://www.marketwatch.com/story/eli-lilly-sales-hit-by-patent-expirations-2015-01-30
Market Place
Share 
